Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes

NARecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

May 14, 2026

Study Completion Date

June 14, 2026

Conditions
Renal Impairment After Cardiac SurgeryRenal ImpairmentAcute Kidney Injury
Interventions
DEVICE

Renal assist device

The JuxtaFlow RAD includes two endoscopically placed ureteral catheters connected to a bedside pump system. The catheters are designed to deliver a mild, controlled negative pressure (-15 mmHg ± 2mmHg) into the renal pelvis of each kidney for up to 72 hours. This pressure is designed to diffuse through each of the million nephrons lowering intratubular pressure thereby improving the filtration gradient at the glomerulus while supporting overall kidney function.

Trial Locations (1)

33331

RECRUITING

Cleveland Clinic Florida, Weston

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

RQM+

INDUSTRY

lead

3ive Labs

INDUSTRY

NCT07017933 - Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes | Biotech Hunter | Biotech Hunter